A Retrospective study to evaluate the survival outcomes of Ipilimumab treatment for metastatic Melanoma in the pre- and post-targeted era
Latest Information Update: 05 Sep 2018
At a glance
- Drugs Ipilimumab (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 05 Sep 2018 New trial record